February 15, 2016.
FDA sent out eight warning letters on earlier this month to various makers of a dietary supplement called cannabidiol, which is derived from the Cannabis plant. Cannabidiol, also known as CBD oil, is described as a nonpsychoactive dietary supplement that is purported to have numerous benefits, including anti-inflammatory and antiemetic properties.
However, FDA said the CBD oil products are being marketed as medications and have not been adequately tested to prove they are safe and effective.
See more on this story at Pharmaceutical Technologyhere.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.